NO20002590D0 - Formulations comprising dissolved paroxetine - Google Patents

Formulations comprising dissolved paroxetine

Info

Publication number
NO20002590D0
NO20002590D0 NO20002590A NO20002590A NO20002590D0 NO 20002590 D0 NO20002590 D0 NO 20002590D0 NO 20002590 A NO20002590 A NO 20002590A NO 20002590 A NO20002590 A NO 20002590A NO 20002590 D0 NO20002590 D0 NO 20002590D0
Authority
NO
Norway
Prior art keywords
formulations
paroxetine
dissolved
dissolved paroxetine
Prior art date
Application number
NO20002590A
Other languages
Norwegian (no)
Other versions
NO20002590L (en
Inventor
Ahmad Ghazawi
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20002590D0 publication Critical patent/NO20002590D0/en
Publication of NO20002590L publication Critical patent/NO20002590L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20002590A 1997-11-21 2000-05-19 Formulations comprising dissolved paroxetine NO20002590L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9724544.3A GB9724544D0 (en) 1997-11-21 1997-11-21 Novel Formulation
PCT/GB1998/003471 WO1999026625A1 (en) 1997-11-21 1998-11-18 Formulations comprising dissolved paroxetine

Publications (2)

Publication Number Publication Date
NO20002590D0 true NO20002590D0 (en) 2000-05-19
NO20002590L NO20002590L (en) 2000-07-19

Family

ID=10822374

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002590A NO20002590L (en) 1997-11-21 2000-05-19 Formulations comprising dissolved paroxetine

Country Status (24)

Country Link
EP (1) EP1033986A1 (en)
JP (1) JP2001523718A (en)
KR (1) KR20010032320A (en)
CN (1) CN1279608A (en)
AP (1) AP2000001821A0 (en)
AR (1) AR015485A1 (en)
AU (1) AU1168099A (en)
BG (1) BG104527A (en)
BR (1) BR9814220A (en)
CO (1) CO4970832A1 (en)
DZ (1) DZ2658A1 (en)
EA (1) EA200000552A1 (en)
GB (1) GB9724544D0 (en)
HU (1) HUP0100580A3 (en)
IL (1) IL136106A0 (en)
MA (1) MA24704A1 (en)
NO (1) NO20002590L (en)
OA (1) OA11385A (en)
PE (1) PE20000381A1 (en)
PL (1) PL340555A1 (en)
SK (1) SK7342000A3 (en)
TR (1) TR200001423T2 (en)
WO (1) WO1999026625A1 (en)
ZA (1) ZA9810637B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9810180D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulation
DE50011819D1 (en) 1999-03-12 2006-01-12 Aesica Pharmaceuticals Ltd STABLE PHARMACEUTICAL APPLICATION FOR PAROXETIN ANHYDRATE
EP1109806B8 (en) 1999-07-01 2003-10-29 Italfarmaco S.p.A. Complexes of paroxetine, with cyclodextrins or cyclodextrin derivates
DE19930454A1 (en) * 1999-07-02 2001-01-04 Knoll Ag Solid paroxetine-containing preparations
US6720003B2 (en) 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
DE60222803T2 (en) * 2001-12-21 2008-07-17 Supernus Pharmaceuticals, Inc. ORAL CAPSULE FORMULATION WITH IMPROVED PHYSICAL STABILITY
SE0200475D0 (en) * 2002-02-15 2002-02-15 Ltp Lipid Technologies Provide Oral pharmaceutical preparation
WO2006119779A2 (en) * 2005-05-10 2006-11-16 Lifecycle Pharma A/S A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution
US20120322752A1 (en) * 2009-12-08 2012-12-20 Sung Kyun Lee SOLID DISPERSIONS CONTAINING 20-O-beta-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL
GB201020032D0 (en) * 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
CN103961333B (en) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 Paroxetine mesylate capsule and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2216934A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
IL130856A (en) * 1997-01-15 2001-09-13 Smithkline Beecham Plc Spray-dried paroxetine compositions and their preparation

Also Published As

Publication number Publication date
OA11385A (en) 2004-01-27
HUP0100580A2 (en) 2002-04-29
MA24704A1 (en) 1999-07-01
AP2000001821A0 (en) 2000-06-30
BG104527A (en) 2001-04-30
JP2001523718A (en) 2001-11-27
IL136106A0 (en) 2001-05-20
SK7342000A3 (en) 2000-12-11
EA200000552A1 (en) 2000-10-30
TR200001423T2 (en) 2000-10-23
HUP0100580A3 (en) 2002-05-28
WO1999026625A1 (en) 1999-06-03
BR9814220A (en) 2001-12-26
PL340555A1 (en) 2001-02-12
AR015485A1 (en) 2001-05-02
GB9724544D0 (en) 1998-01-21
ZA9810637B (en) 2000-05-22
KR20010032320A (en) 2001-04-16
NO20002590L (en) 2000-07-19
EP1033986A1 (en) 2000-09-13
AU1168099A (en) 1999-06-15
DZ2658A1 (en) 2003-03-22
CO4970832A1 (en) 2000-11-07
CN1279608A (en) 2001-01-10
PE20000381A1 (en) 2000-05-07

Similar Documents

Publication Publication Date Title
IS5555A (en) Selekoxib formulations
ID30031A (en) AGROKIMIA FORMULATIONS
ID23546A (en) ZIPRASIDON FORMULATIONS
NO992339L (en) Pharmaceutical Formulations
MA24473A1 (en) FORMULATIONS
NO20004240L (en) formulations
ATE224703T1 (en) EFFORTABLE FORMULATIONS
DE59802860D1 (en) DISINFECTANT
PT1130966E (en) ANTIPARASITARY FORMULATIONS
NO20001631L (en) 2-methyl-thieno-benzodiazepine formulation
DE60000003T2 (en) paroxetine
CY2006006I1 (en) PROTEIN FORMULATIONS
NO980546D0 (en) Pharmaceutical agents
DE69805807D1 (en) MICROBIOCIDES N-SULFONYLGLYCINE ALKYNYLOXYPHENETHYLAMIDE DERIVATIVES
IS6398A (en) formulations
DE69935609D1 (en) FORMULATIONS CONTAINING CEFUROXIM-AXETIL
NO993460D0 (en) Paroxetine compositions
DE69833493D1 (en) TISSUE
NO20002590D0 (en) Formulations comprising dissolved paroxetine
IS5184A (en) pharmaceutical compositions
DE59812037D1 (en) INSECTICIDE-CONTAINING FORMULATIONS
EE200000330A (en) Pharmaceutical compositions
IS5260A (en) Dissolved sertraline formulations
DE29718933U1 (en) horseshoe
NO994436L (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application